High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

November 30, 2021

Conditions
Covid19Vitamin D DeficiencyCorona Virus InfectionARDSCoronavirusSARS-CoV Infection
Interventions
DRUG

Single high dose vitamin D

Patient receives either one dose orally of 140'000 IU (7 ml) of this drug once as an intervention treatment additionally to TAU or the patient receives 7 ml of the placebo Solution (7 ml) in addition to TAU

DRUG

Placebo

Patient receives a single dose of a placebo solution

DRUG

Treatment as usual vitamin D

Both groups receive the treatment as usual after the single high dose or the placebo which will be 800 IU per day

Trial Locations (2)

4410

Cantonal Hospital Baselland Liestal, Liestal

9001

Cantonal Hospital St. Gallen, Sankt Gallen

All Listed Sponsors
lead

Prof. Dr. Jörg Leuppi

OTHER

NCT04525820 - High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study | Biotech Hunter | Biotech Hunter